351
Participants
Start Date
October 11, 2012
Primary Completion Date
July 1, 2016
Study Completion Date
July 1, 2016
Bevacizumab
Bevacizumab will be administered as per approved label.
Chemotherapy
The protocol does not specify the chemotherapy regimen to be used, the choice of chemotherapy will be at the discretion of treating physician.
Tri-Service General Hospital; Hematology and Oncology, Taipei
Chang Gung Medical Foundation - Linkou; Colo-rectal Surgery, Taoyuan District
Taichung Veterans General Hospital; Dept of Surgery, Taichung
Chang Gung Medical Foundation - Chai Yi; Surgery, CHAI YI
National Cheng Kung Uni Hospital; Dept of Hematology and Oncology, Tainan City
Kaohsiung Medical Uni Chung-Ho Hospital; Dept of Surgery, Kaohsiung City
Kaohsiung Chang Gung Memorial Hospital; Colorectal Surgery, Kaohsiung City
Veterans General Hospital; Division of Oncology, Taipei
Mackay Memorial Hospital; Department of Surgery, Division of Colon and Rectal Surgery, Taipei
Hoffmann-La Roche
INDUSTRY